These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23274456)

  • 21. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized medicine: factors influencing reimbursement.
    Meckley LM; Neumann PJ
    Health Policy; 2010 Feb; 94(2):91-100. PubMed ID: 19815307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues.
    Gillis NK; Innocenti F
    Clin Pharmacol Ther; 2014 Dec; 96(6):655-7. PubMed ID: 25399714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reviewing pharmacogenetics to advance precision medicine for opioids.
    Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
    Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of research into genetics and the precision dosing of tacrolimus: what do we need to know?
    Zhu J; Pasternak AL; Crona DJ
    Pharmacogenomics; 2020 Oct; 21(15):1061-1064. PubMed ID: 32896220
    [No Abstract]   [Full Text] [Related]  

  • 28. Genomic testing is best integrated into clinical practice when it is actionable.
    Hendricks-Sturrup RM; Linsky A; Lu CY; Vassy JL
    Per Med; 2020 Jan; 17(1):5-8. PubMed ID: 31795838
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetic testing: time for clinical practice guidelines.
    Amstutz U; Carleton BC
    Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized medicine into health national services: barriers and potentialities.
    Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
    Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
    de Leon J; Spina E
    Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
    Reynolds KK; Pierce DL; Weitendorf F; Linder MW
    Per Med; 2017 May; 14(3):221-233. PubMed ID: 29767587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
    Fan M; Bousman CA
    Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer: updated guideline recommendations for HER2 testing.
    Rakha EA; Ellis IO
    Nat Rev Clin Oncol; 2014 Jan; 11(1):8-9. PubMed ID: 24322598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
    Palapattu GS
    J Urol; 2017 Aug; 198(2):265-266. PubMed ID: 28629664
    [No Abstract]   [Full Text] [Related]  

  • 39. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic research in partnership with American Indian and Alaska Native communities.
    Woodahl EL; Lesko LJ; Hopkins S; Robinson RF; Thummel KE; Burke W
    Pharmacogenomics; 2014 Jun; 15(9):1235-41. PubMed ID: 25141898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.